Status:
UNKNOWN
Wearable Devices for Secondary Prevention of Ischemic Stroke
Lead Sponsor:
Campus Bio-Medico University
Conditions:
Stroke, Ischemic
Atrial Fibrillation
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Ischemic stroke is an important cause of death and disability in Western countries. Different risk factors have been identified such as hypertension, diabetes, dyslipidemia, smoke, atrial fibrillation...
Eligibility Criteria
Inclusion
- Age greater than or equal 50 years
- Recent transient ischemic attack or minor stroke
Exclusion
- Patients with significant cognitive impairment
- Patients dependent in the instrumental activities of daily life
- Patients not able to respect the frequency of monitoring program
- Patients with history of atrial fibrillation
Key Trial Info
Start Date :
April 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04282993
Start Date
April 16 2019
End Date
June 30 2022
Last Update
February 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Università Campus Bio-Medico di Roma
Roma, RM, Italy, 00128